fenofibrate and allylamine

fenofibrate has been researched along with allylamine in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	5 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, BA; Jones, MR; Mathew, P	1
Abby, S; Jones, M; McKenney, J	1
Keating, GM; Robinson, DM	1
Elisaf, MS; Florentin, M; Liberopoulos, EN; Mikhailidis, DP	1
Robinson, JG	1

Reviews

3 review(s) available for fenofibrate and allylamine

Article	Year
Colesevelam: a review of its use in hypercholesterolemia. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2007, Volume: 7, Issue:6 Topics: Allylamine; Anticholesteremic Agents; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Therapy, Combination; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents	2007
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia. Current medical research and opinion, 2008, Volume: 24, Issue:4 Topics: Allylamine; Anticholesteremic Agents; Apolipoproteins B; Azetidines; Bile Acids and Salts; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Risk Factors	2008
LDL reduction: how low should we go and is it safe? Current cardiology reports, 2008, Volume: 10, Issue:6 Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Muscular Diseases; Niacin; Risk Factors; Stroke	2008

Trials

2 trial(s) available for fenofibrate and allylamine

Article	Year
Effect of colesevelam HCl on single-dose fenofibrate pharmacokinetics. Clinical pharmacokinetics, 2004, Volume: 43, Issue:13 Topics: Adult; Allylamine; Area Under Curve; Colesevelam Hydrochloride; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Female; Fenofibrate; Food-Drug Interactions; Half-Life; Humans; Hypolipidemic Agents; Male; Time Factors	2004
Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia. Current medical research and opinion, 2005, Volume: 21, Issue:9 Topics: Allylamine; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Male; Middle Aged; Safety; Treatment Outcome	2005

Article

Year

Effect of colesevelam HCl on single-dose fenofibrate pharmacokinetics.

Clinical pharmacokinetics, 2004, Volume: 43, Issue:13

Topics: Adult; Allylamine; Area Under Curve; Colesevelam Hydrochloride; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Female; Fenofibrate; Food-Drug Interactions; Half-Life; Humans; Hypolipidemic Agents; Male; Time Factors

2004

Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia.

Current medical research and opinion, 2005, Volume: 21, Issue:9

Topics: Allylamine; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Female; Fenofibrate; Humans; Hyperlipoproteinemia Type V; Hypolipidemic Agents; Male; Middle Aged; Safety; Treatment Outcome

2005